glp-1 shortage over Out of Shortage, Into Controversy: The Fight Compounding As GLP-1 Drug Shortage Ends,

Diabetes Metab 46(6):427441

Progression to kidney replacement therapy (KRT) occurred in 3.7% of patients receiving GLP-1 receptor agonists

Consistent with the binding affinities acquired by SPR, GLP-1 LX exhibited the weakest binding and dissociated from the column first at pH 6.3, followed by GLP-1 WT at pH 6.7 and Tanzeum at pH 6.9 (Fig

doi: 10.3389/fendo.2021.585887

Future research must address these gaps, focusing on long-term safety, optimizing combination approaches, and evaluating the broader clinical and economic implications of widespread GLP-1 RA use

These psychiatric disorders are highly associated with metabolic disorders like obesity, cardiovascular disease, asthma and diabetes- the key markets proposed for the drugs